Femasys Inc
NASDAQ:FEMY
Femasys Inc
Net Income (Common)
Femasys Inc
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Femasys Inc
NASDAQ:FEMY
|
Net Income (Common)
-$14.2m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Net Income (Common)
$1.2B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
3%
|
|
Boston Scientific Corp
NYSE:BSX
|
Net Income (Common)
$1.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
Stryker Corp
NYSE:SYK
|
Net Income (Common)
$3.2B
|
CAGR 3-Years
26%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
12%
|
|
Abbott Laboratories
NYSE:ABT
|
Net Income (Common)
$5.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
17%
|
CAGR 10-Years
9%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Net Income (Common)
$2B
|
CAGR 3-Years
19%
|
CAGR 5-Years
12%
|
CAGR 10-Years
14%
|
See Also
What is Femasys Inc's Net Income (Common)?
Net Income (Common)
-14.2m
USD
Based on the financial report for Dec 31, 2023, Femasys Inc's Net Income (Common) amounts to -14.2m USD.
What is Femasys Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 3Y
-27%
Over the last year, the Net Income (Common) growth was -25%. The average annual Net Income (Common) growth rates for Femasys Inc have been -27% over the past three years .